Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)-Reference-Cited by-同舟云学术

Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

Published:2019-04 Issue:S1 Volume:36 Page:145-159
ISSN:1170-229X
Container-title:Drugs & Aging
language:en
Short-container-title:Drugs Aging

Author:

Honvo Germain^ORCID,Bannuru Raveendhara R.,Bruyère Olivier,Rannou Francois,Herrero-Beaumont Gabriel,Uebelhart Daniel,Cooper Cyrus,Arden Nigel,Conaghan Philip G.,Reginster Jean-Yves,Thomas Thierry,McAlindon Tim

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Geriatrics and Gerontology

Link

http://link.springer.com/content/pdf/10.1007/s40266-019-00667-8.pdf

Reference95 articles.

1. Ioannidis JPA, Lau J. Completeness of safety reporting in randomized trials. JAMA. 2001;285(4):437–43. https://doi.org/10.1001/jama.285.4.437 .

2. Golder S, Loke YK, Wright K, Norman G. Reporting of adverse events in published and unpublished studies of health care interventions: a systematic review. PLoS Med. 2016;13(9):1–22. https://doi.org/10.1371/journal.pmed.1002127 .

3. Rodgers MA, Brown JVE, Heirs MK, Higgins JPT, Mannion RJ, Simmonds MC, et al. Reporting of industry funded study outcome data: comparison of confidential and published data on the safety and effectiveness of rhBMP-2 for spinal fusion. BMJ (Online). 2013;347(7915):1–14. https://doi.org/10.1136/bmj.f3981 .

4. Schroll JB, Penninga EI, Gøtzsche PC. Assessment of adverse events in protocols, clinical study reports, and published papers of trials of orlistat: a document analysis. PLoS Med. 2016;13(8):1–14. https://doi.org/10.1371/journal.pmed.1002101 .

5. Hodkinson A, Gamble C, Smith CT. Reporting of harms outcomes: a comparison of journal publications with unpublished clinical study reports of orlistat trials. Trials. 2016;17(1):1–11. https://doi.org/10.1186/s13063-016-1327-z .

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recommendations for the optimal use of bone forming agents in osteoporosis;Aging Clinical and Experimental Research;2024-08-09

2. Evidence-Based Guideline for the management of osteoporosis in men;Nature Reviews Rheumatology;2024-03-14

3. Basic-helix-loop-helix family member e41 suppresses osteoclastogenesis and abnormal bone resorption disease via NFATc1;iScience;2024-03

4. Research progress in arthritis treatment with the active components of Herba siegesbeckiae;Biomedicine & Pharmacotherapy;2023-12

5. Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging;Calcified Tissue International;2023-01-12